DBV Technologies | Resultado Líquido



Net Income Alterar Data
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amarin USD -25134000 26.66M 2024-09
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
DBV Technologies USD -30442000 2.67M 2024-09
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
Incyte USD 158.2M 43.01M 2025-03
Insmed USD -256583000 21.04M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
United Therapeutics USD 322.2M 20.9M 2025-03



DBV Technologies Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.